Growing community of inventors

Tampere, Finland

Olli Oksala

Average Co-Inventor Count = 4.17

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 47

Olli OksalaKari Lehmussaari (5 patents)Olli OksalaTimo Reunamaki (5 patents)Olli OksalaPertti Pellinen (2 patents)Olli OksalaSakari Alaranta (2 patents)Olli OksalaEija Vartiainen (2 patents)Olli OksalaJarkko Ruohonen (1 patent)Olli OksalaEsko Pohjala (1 patent)Olli OksalaMarkku Peralampi (1 patent)Olli OksalaOlli Oksala (5 patents)Kari LehmussaariKari Lehmussaari (6 patents)Timo ReunamakiTimo Reunamaki (5 patents)Pertti PellinenPertti Pellinen (2 patents)Sakari AlarantaSakari Alaranta (2 patents)Eija VartiainenEija Vartiainen (2 patents)Jarkko RuohonenJarkko Ruohonen (2 patents)Esko PohjalaEsko Pohjala (7 patents)Markku PeralampiMarkku Peralampi (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Santen Oy (3 from 4 patents)

2. Asahi Glass Company, Limited (1 from 2,560 patents)

3. Agc Inc. (1 from 1,027 patents)

4. Santen Pharmaceutical Co., Ltd. (1 from 282 patents)

5. Santen Pharmaceuticalco., Ltd. (1 from 2 patents)


5 patents:

1. 10864159 - Method and composition for treating ocular hypertension and glaucoma

2. 9999593 - Method and composition for treating ocular hypertension and glaucoma

3. 5795913 - Ophthalmic composition

4. 5767143 - Ophthalmological preparation

5. 5710182 - Ophthalmic composition

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/2/2026
Loading…